[Facial pain].
D000212:Acyclovir / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001418:Baclofen / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D002574:Cervical Vertebrae; D003027:Cluster Headache / Q000175:diagnosis / Q000628:therapy; D004359:Drug Therapy, Combination; D004878:Ergotamine / Q000627:therapeutic use; D005128:Eye Diseases / Q000209:etiology; D005157:Facial Pain / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D005260:Female; D013700:Giant Cell Arteritis / Q000175:diagnosis / Q000628:therapy; D006261:Headache / Q000209:etiology; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008297:Male; D008784:Methysergide / Q000627:therapeutic use; D008875:Middle Aged; D010003:Osteoarthritis / Q000150:complications; D010038:Otorhinolaryngologic Diseases / Q000150:complications; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000627:therapeutic use; D013706:Temporomandibular Joint Dysfunction Syndrome / Q000175:diagnosis; D014277:Trigeminal Neuralgia / Q000175:diagnosis / Q000628:therapy; D014740:Vidarabine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D002121:Calcium Channel Blockers; D011619:Psychotropic Drugs; D002220:Carbamazepine; D008094:Lithium; D014740:Vidarabine; D001418:Baclofen; D004878:Ergotamine; D000212:Acyclovir; D008784:Methysergide
Les algies faciales.